Tarsus Pharmaceuticals Chief Medical Officer Lin Elizabeth Yeu sold 11,578 shares in three transactions priced from $73.86 to $80 per share. For investors, the disclosure also identifies Yeu’s post-sale holding at 4,770 shares, showing the stake that remained after the reported transactions.

Key Highlights

  • The transactions occurred between September 1 and September 2.
  • Lin Elizabeth Yeu owned 4,770 shares after the transactions.
  • Each reported transaction carried sales code S.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Chief Medical Officer Lin Elizabeth Yeu sold 11,578 shares across three transactions at prices ranging from $73.86 to $80 per share. The transactions took place between September 1 and September 2.

Yeu’s Remaining Tarsus Stake

Yeu held 4,770 shares after completing the transactions. The reported activity consisted of three separate sales, each identified with transaction code S. Lin Elizabeth Yeu serves as Tarsus Pharmaceuticals’ Chief Medical Officer. The transactions covered the stated price range of $73.86 to $80 per share.